“Tackling the pandemic probably requires, in addition to a vaccine, a preventive or early-acting drug,” said Kalervo Väänänen, one of the three inventors and founders of Therapeutica Borealis. “This drug also helps especially in a situation where vaccine coverage threatens to remain too low for herd immunity.”